Web annex C: safety of dolutegravir in pregnancy and breastfeeding: updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines. Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection

View/ Open
Citation
World Health Organization & Mofenson, L. (2018). Web annex C: safety of dolutegravir in pregnancy and breastfeeding: updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines. Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. World Health Organization. https://apps.who.int/iris/handle/10665/276491. License: CC BY-NC-SA 3.0 IGO
Description
8 p.Document number
WHO/CDS/HIV/18.26Language
EnglishCollections
Metadata
Show full item recordRelated items
Showing items related by title and subject
-
World Health Organization; Shubber, Z.; Ford, N. (World Health Organization, 2018)
-
World Health Organization (World Health Organization, 2018)
-
World Health Organization (World Health Organization, 2018)